Is Bioxyne Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Bioxyne Ltd (BXN.AX) is currently classified as HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Bioxyne Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bioxyne Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Bioxyne Ltd?

Muslim investors may consider investing in Bioxyne Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bioxyne Ltd classified as HALAL?

Musaffa determines the Shariah status of Bioxyne Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bioxyne Ltd updated?

The Shariah compliance status of Bioxyne Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bioxyne Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bioxyne Ltd?

You can check the latest Shariah compliance status of Bioxyne Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BXN.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: October 20, 2025

Report Source: 2025 Annual Report

Bioxyne Ltd. Stock Analysis BXN.AX

Australia Health Care Micro Cap Report: 2025 Annual

Bioxyne Ltd. engages in the research, development, market and distribution of health products. The firm is focused on health and wellness products, psychotropic and investigational medicines. The firm operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The firm direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.

Key Statistics of Bioxyne Ltd (BXN.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.08AUD0.09

Today's Open

AUD0.08

Volume

5.30M

P/E Ratio (TTM)

38.92

52 Week Range

AUD0.02AUD0.09

Market Cap

131.69M

Avg. Volume

983.20K

Dividend Yield

Financial Metrics & Statements of Bioxyne Ltd (BXN.AX)

FAQ's for Bioxyne Ltd (BXN.AX)

According to Musaffa’s Shariah screening methodology, Bioxyne Ltd (BXN.AX) is currently classified as HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.